How do you take an invention further and make the right decisions to protect your innovation? Patent engineer Maria Lundström provides a helping hand in the delicate processes of patents,
Biotage announces the closing of the acquisition of all outstanding shares in the privately held company Horizon Technology, based in New Hampshire, US, in accordance with contract and public announcement of December
Cholesterol metabolites cause specific immune cells in the large intestine to move, which lies behind the formation of the immune system’s important lymphoid tissue in the intestine, reports researchers at
The company has received a positive outcome from the NAD (National Advertising Division) regarding a challenge filed on Fungi-Nail, the largest US competitor to the Kerasal Nail product. NAD recommends
The US Food and Drug Administration has approved Lynparza (olaparib), for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who
The company has received authorization to conduct a phase I/II clinical study on the quadrivalent influenza vaccine candidate Immunose FLU, a novel nose drop formulation based on the company´s technology
The European Commission has approved Fasenra (benralizumab) as an add-on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long-acting beta-agonists. Their first respiratory biologic
The Chinese patent office, the State Intellectual Property Office, has formally approved the company’s patent application for IL1RAP as target molecule for antibody therapy of several types of solid tumours.
In facilities where medical research is pioneering new treatments and cures, the viewLinc system safeguards crucial samples, processes and products.